CDEK
← All organizations

Yamanouchi Pharmaceuticals

For profitContributed to NME

Also known as: Yamanouchi | YAMANOUCHI

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2002

First marketed drug

Nov 19, 2004

First NDA

Nov 19, 2004

Last known activity

Feb 1, 2002

Acquired by Astellas → Leo Pharma on Jan 1, 2005

Timeline

1920s

  1. Jan 1, 1923

    Yamanouchi Pharmaceuticals— Founded

2000s

  1. Nov 19, 2004

    solifenacin— NDA Organization

  2. Jan 1, 2005

    Astellas— Acquired By

2010s

  1. Nov 17, 2015

    Leo Pharma— Now

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (2)

Recent trials (1)

Details

Founded
Osaka, JP Jan 1, 1923
First NDA
Nov 19, 2004
Last known activity
Feb 1, 2002